Open Herald: Periodical of Methodical Research

Serum Fucose Level is a Reliable Biomarker to Astrocytoma: Case-control study-A systematic study and meta-analysis

Nagham qasim kadhim

Department of Biochemistry, College of Science, Tikrit University, IRAQ

Saif Mahmood Al-Faraji

Ministry of Education, Salah El-Din General Directorate/Open Educational College, Salah El-Din Study Center, Tikrit, Iraq

Mohammed Asker Mohammed

Department of Biochemistry, College of Science, Tikrit University, IRAQ

Keywords: Fucose, Astrocytomas, Cancer, Malignant

---

Abstract

Cancer is one of the main leading diseases causing death. The current study aims to evaluate the concentration of fucose in the blood serum of astrocytoma patients. Also, a systematic study with sequential meta-analysis was performed. Web of Science, PubMed, EBSCO and Scopus, and published reference lists were searched up to end of May 2023. This meta-analysis indicates a statistically significant mean difference in fucose in serum between cancer patients and controls . The current search included 12 of 3611 titles: 562 cancer cases and 401 normal. Meta-analysis concluded that serum fucose can differentiate cancer patients from controls. Significant heterogeneity was found between studies: P < 0.0001 and I2 94.48%. A significant publication bias was observed (Begg, p = 0007; E gger, p = 0. 00092). there was a differences in Forest Plot of TF level between patients and control groups. Also, study estimated pooled effect size

---

References

- Piña-Sánchez P, Chávez-González A, Ruiz-Tachiquín M, Vadillo E, Monroy-García A,

Montesinos JJ, Grajales R, Gutiérrez de la Barrera M, Mayani H. Cancer Biology,

Epidemiology, and Treatment in the 21st Century: Current Status and Future Challenges From

a Biomedical Perspective. Cancer Control. 2021 Jan-Dec;28:10732748211038735.

- Yue, J., Huang, R., Lan, Z. et al. Abnormal glycosylation in glioma: related changes in

biology, biomarkers and targeted therapy. Biomark Res 11, 54 (2023).

- Thomas D, Rathinavel AK, Radhakrishnan P. Altered glycosylation in cancer: A

promising target for biomarkers and therapeutics. Biochim Biophys Acta Rev Cancer.

Jan;1875(1):188464.

- Y. Tan, Y. Zhang, Y. Han, H. Liu, H. Chen, F. Ma, S. G. Withers, Y. Feng, G. Yang,

Directed evolution of an α1,3-fucosyltransferase using a single-cell ultrahighthroughput screening method. Sci. Adv.5, eaaw8451 (2019).

- Fang, K., Long, Q., Liao, Z. et al. Glycoproteomics revealed novel N-glycosylation biomarkers

for early diagnosis of lung adenocarcinoma cancers. Clin Proteom 19, 43 (2022).

- Wilczak M, Surman M, Przybyło M. Altered Glycosylation in Progression and Management of

Bladder Cancer. Molecules. 2023 Apr 13;28(8):3436. doi: 10.3390/molecules28083436.

- Visconti, A., Rossi, N., Deriš, H. et al. Total serum N-glycans associate with response to

immune checkpoint inhibition therapy and survival in patients with advanced melanoma. BMC

Cancer 23, 166 (2023).

- Veyssière, H., Bidet, Y., Penault-Llorca, F. et al. Circulating proteins as predictive and

prognostic biomarkers in breast cancer. Clin Proteom 19, 25 (2022).

- Kudelka MR, Lasanajak Y, Smith DF, Song X, Hossain MS, Owonikoko TK. Serum glycomic

profile as a predictive biomarker of recurrence in patients with differentiated thyroid cancer.

Cancer Med. 2023 Mar;12(6):6768-6777. doi: 10.1002/cam4.5465. Epub 2022 Nov 27.

- Fu J, Guo Q, Feng Y, Cheng P, Wu A. Dual role of fucosidase in cancers and its clinical

potential. J Cancer. 2022 Aug 15;13(10):3121-3132.

- Keeley, T.S.; Yang, S.; Lau, E. The Diverse Contributions of Fucose Linkages in Cancer.

Cancers 2019, 11, 1241.

- Antonarelli G, Pieri V, Porta FM, Fusco N, Finocchiaro G, Curigliano G, Criscitiello C.

Targeting Post-Translational Modifications to Improve Combinatorial Therapies in Breast

Cancer: The Role of Fucosylation. Cells. 2023 Mar 8;12(6):840.

- Chaulagain D, Smolanka V, Smolanka A. Diagnosis and management of astrocytoma: A

literature review. Int Neurol J. 2022;18(1):23-29.

- Dische Z, Shettles LB. A specific color reaction of methylpentoses and a spectrophotometric

micromethod for their determination. J Biol Chem. 1948;175:595–603.

- Winzler RJ. Determination of serum glycoproteins. Methods Biochem Anal. 1955;2:279–311.

- Park HY, Suh CH, Woo S, Kim PH, Kim KW. Quality Reporting of Systematic Review and

Meta-Analysis According to PRISMA 2020 Guidelines: Results from Recently Published

Papers in the Korean Journal of Radiology. Korean J Radiol. 2022 Mar;23(3):355-369.

- Al-Khabori M, Rasool W. Introduction to Systematic Reviews and Meta-analyses of

Therapeutic Studies. Oman Med J. 2022 Sep 30;37(5):e428.

- Brooke, B. S., Schwartz, T. A. & Pawlik, T. M. MOOSE Reporting Guidelines for Metaanalyses of Observational Studies. JAMA Surg. 156, 787–788 (2021).

- López-Nicolás, R., López-López, J. A., Rubio-Aparicio, M., & SánchezMeca, J. (2021). A

meta-review of transparency and reproducibility-related reporting practices in published metaanalyses on clinical psychological interventions (2000-2020). Behavior Research Methods.

Advance online publication.

- Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D.,

Shamseer, L., Tetzlaff, J. M., Aki, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J.

M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S.,

…Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting

systematic reviews. British Medical Journal, 372, 1-9.

- Zhang D, Huang WJ, Lan MQ, et al. Association between serum amyloid A levels and

predicting disase severity in COVID-19 patients: a systematic review and metaanalysis. Eur

Rev Med Pharmacol Sci. 2021;25:4627-38.

- Xun Y, Guo Q, Ren M, Liu Y, Sun Y, Wu S, Lan H, Zhang J, Liu H, Wang J, Shi Q, Wang Q ,

Wang P, Chen Y, Shao R and Xu DR., (2023), Characteristics of the sources, evaluation, and

grading of the certainty of evidence in systematic reviews in public health: A methodological

study. Front. Public Health 11:998588.

- Schlattmann, P. (2023). Tutorial: statistical methods for the meta-analysis of diagnostic test

accuracy studies. Clinical Chemistry and Laboratory Medicine (CCLM), 61(5), 777-794.

- Blázquez-Rincón, D., Sánchez-Meca, J., Botella, J. et al. Heterogeneity estimation in metaanalysis of standardized mean differences when the distribution of random effects departs from

normal: A Monte Carlo simulation study. BMC Med Res Methodol 23, 19 (2023).

- Bowden J, Tierney JF, Copas AJ, Burdett S. Quantifying, displaying and accounting for

heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC

Med Res Methodol 2011; 11: 41-41.

- Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias.

Biometrics 1994; 50: 1088-1101.

- Winzler RJ. In: Methods of biochemical analysis. Glick D, editor. New York: Interscience

Publishers Inc; 1955. pp. 279–377.